880 WINTER STREET, WALTHAM, MA
Vice President of Finance Resignation; Jason Amello Appointed Principal Accou...
Financial Results, Press Release
Investor Presentation
Retention Program Approved for Key Employees at TScan Therapeutics
Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Changes in Board, Management or Compensation
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload